• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Euro Surveill. Indications for worldwide increased norovirus activity associated with emergence of a new variant of genotype II.4, late 2012

Giuseppe

Emeritus
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]

Eurosurveillance, Volume 18, Issue 1, 03 January 2013

Rapid communications

Indications for worldwide increased norovirus activity associated with emergence of a new variant of genotype II.4, late 2012


J van Beek ()<SUP>1</SUP>, K Ambert-Balay<SUP>2</SUP>, N Botteldoorn<SUP>3</SUP>, J S Eden<SUP>4</SUP>, J Fonager<SUP>5</SUP>, J Hewitt<SUP>6</SUP>, N Iritani<SUP>7</SUP>, A Kroneman<SUP>1</SUP>, H Vennema<SUP>1</SUP>, J Vinj?<SUP>8</SUP>, P A White<SUP>4</SUP>, M Koopmans<SUP>1</SUP>, on behalf of NoroNet<SUP>9</SUP>
  1. National Institute for Public Health and the Environment, Bilthoven, The Netherlands
  2. National Reference Centre for Enteric Viruses, Dijon, France
  3. Scientific Institute of Public Health, Brussels, Belgium
  4. University of New South Wales, Sydney, Australia
  5. Statens Serum Institut, Copenhagen, Denmark
  6. Institute of Environmental Science and Research, Porirua, New Zealand
  7. Osaka City Institute of Public Health and Environmental Sciences, Osaka, Japan
  8. Centers for Disease Control and Prevention, Atlanta, GA, United States
  9. http://www.noronet.nl
<HR>
Citation style for this article: van Beek J, Ambert-Balay K, Botteldoorn N, Eden JS, Fonager J, Hewitt J, Iritani N, Kroneman A, Vennema H, Vinj? J, White PA, Koopmans M, on behalf of NoroNet. Indications for worldwide increased norovirus activity associated with emergence of a new variant of genotype II.4, late 2012. Euro Surveill. 2013;18(1):pii=20345. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20345
Date of submission: 18 December 2012
<HR>Globally, surveillance systems showed an increase in norovirus activity in late 2012. Molecular data shared through the NoroNet network suggest that this increase is related to the emergence of a new norovirus genotype II.4 variant, termed Sydney 2012. Healthcare institutions are advised to be prepared for a severe norovirus season.
- -------
 
Back
Top